N-acetyldopamine,
N-acetyldopamine hydrobromide,
N-Acetyldopamine,
2494-12-4,
N-Acetyldopamine monohydrate,
n-[2-(3,4-dihydroxyphenyl)ethyl]acetamide,
NSC 314644,
CHEMBL137743,
N-(3,4-Dihydroxyphenethyl)acetamide,
BRN 2806306,
Acetamide, N-(3,4-dihydroxyphenethyl)-,
Acetamide,N-[2-(3,4-dihydroxyphenyl)ethyl]-,
Acetamide, N-(2-(3,4-dihydroxyphenyl)ethyl)-,
Acetamide, N-[2-(3,4-dihydroxyphenyl)ethyl]-,
Acetamide, N-(3,4-dihydroxyphenethyl)- (7CI,8CI),
N-acetyl-dopamine,
7DP,
AC1L2OXA,
Lopac-A-8762,
Lopac0_000093,
SCHEMBL328568,
AC1Q5P51,
Acetamide,4-dihydroxyphenethyl)-,
CTK4F4676,
DTXSID70179656,
CHEBI:125678,
ZINC402700,
Acetamide,4-dihydroxyphenyl)ethyl]-,
BDBM50035608,
NSC314644,
AKOS003589558,
N-(3,4-Dihydroxyphenethyl)-Acetamide,
CCG-204188,
LS-9248,
NSC-314644,
VZ33103,
NCGC00015101-01,
NCGC00015101-02,
NCGC00015101-03,
NCGC00093595-01,
NCGC00093595-02,
EU-0100093,
A 8762,
{N-[2-(3,} 4-dihydroxyphenyl)ethyl]-Acetamide,
N-[2-(3,4-dihydroxyphenyl)ethyl]ethanimidic acid,
SR-01000075692,
SR-01000075692-1,
BRD-K95847244-001-01-9,
N-(2-(3,4-Dihydroxyphenyl)ethyl)acetamide (ACD/Name 4.0),
NADA,
N-acetyldopamine hydrobromide,
AR-1K3565,
CID100526,
~{n}-[2-[3,4-Bis(Oxidanyl)phenyl]ethyl]ethanamide,
C006374,
19431-21-1,